Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area

Journal of Hepatology

Volumn 42, Issue 6, 2005, Pages 813-819

  Hui, Chee Kin ^a   Sun, Jian ^b   Au, Wing Yan ^a   Lie, Albert K W ^a   Yueng, Yui Hung ^a   Zhang, Hai Ying ^a   Lee, Nikki P ^a   Hou, Jin Ling ^b   Liang, Raymond ^a   Lau, George K K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Namfang Hospital   (China)

Author keywords

Hematopoietic stem cell transplantation; Occult HBV; Prevalence of occult HBV

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMATOPOIETIC STEM CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SERUM; STATISTICAL SIGNIFICANCE; VIRUS CORE; VIRUS INFECTION;

ADULT; BLOOD DONORS; CARRIER STATE; DNA, VIRAL; ENDEMIC DISEASES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HONG KONG; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 21044433150     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.01.018     Document Type: Article

References (40)

1. R.P. Perrillo Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease Gastroenterology 120 2001 1009 1022
2. J.H. Hoofnagle, G.M. Dusheiko, D.F. Schafer, E.A. Jones, K.C. Micekitch, and R.C. Young Reactivation of chronic hepatitis B infection by cancer chemotherapy Ann Intern Med 96 1982 447 449
3. A.S. Lok, R.H. Liang, E.K. Chiu, K.L. Wong, T.K. Chan, and D. Todd Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 1991 182 188
4. B. Rehermann, C. Ferrari, C. Pasquinelli, and F.V. Chisari The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T lymphocyte response Nat Med 2 1996 1104 1108
5. J. Blackberg, and K. Kidd-Ljunggren Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation J Hepatol 33 2000 992 997
6. C. Brechot, V. Thiers, D. Kremsdorf, B. Nalpas, S. Pol, and P. Paterlini-Brechot Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 34 2001 194 203
7. Y.M. Lo, E.S. Lo, W.Z. Mehal, M. Sampieto, G. Fiorelli, and G. Ronchi Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients J Clin Pathol 46 1993 304 308
8. R. Fukuda, N. Ishimura, S. Hamamoto, M. Moritani, Y. Uchida, and S. Ishihara Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver J Med Virol 63 2001 220 227
9. W. Jilg, E. Sieger, R. Zachoval, and H. Schatzl Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus J Hepatol 23 1995 14 20
10. R. Fukuda, N. Ishimura, M. Niigaki, S. Hamamoto, S. Satoh, and S. Tanaka Serologically silent hepatitis B virus co-infection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance J Med Virol 58 1999 201 207
11. T. Uchida, Y. Kaneita, K. Gotoh, H. Kanagawa, H. Kouyama, and T. Kawanishi Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection J Med Virol 52 1997 399 405
12. K. Koike, M. Kobayashi, M. Gondo, I. Hayashi, T. Osuga, and S. Takada Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients J Med Virol 54 1999 249 255
13. K. Nirei, M. Kaneko, M. Moriyama, and Y. Arakawa The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen Intervirology 43 2000 95 101
14. L. Kazemi-Shirazi, D. Petermann, and C. Muller Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C J Hepatol 33 2000 785 790
15. E. Villa, A. Grottola, P. Buttafoco, P. Trande, A. Merigi, and N. Fratti Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B Dig Dis Sci 40 1995 8 13
16. N. De Maria, A. Colantoni, L. Friedlander, G. Leandro, R. Idilman, and J. Harig The impact of previous HBV infection on the course of chronic hepatitis C Am J Gastroenterol 95 2000 3529 3536
17. M.J. Gandhi, G.G. Yang, B.J. McMahon, and G.N. Vyas Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viraemia by PCR in Alaska Native HBV carriers who have seroconverted Transfusion 40 2000 910 916
18. R. Fukuda, N. Ishimura, Y. Kushiyama, N. Moriyama, S. Ishihara, and A. Chowdhury Hepatitis B virus with X gene mutation is associated with the majority of serologically 'silent' non-b, non-c chronic hepatitis Microbiol Immunol 40 1996 481 488
19. D.S. Lee, K. Huh, E.H. Lee, D.H. Lee, K.S. Hong, and Y.C. Sung HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of co-infection in these patients must be considered in HBV-high endemic area J Gastroenterol Hepatol 12 1999 855 861
20. J. Stransky, L. Malina, B. Cieslarova, J. Stritesky, I. Putova, and J. Horak Overt and hidden co-infection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda Acta Virol 44 2000 23 28
21. I. Cacciola, T. Pollicino, G. Squadrito, G. Cerenzia, M.E. Orlando, and G. Raimondo Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Eng J Med 341 1999 22 26
22. G.Y. Minuk, D.F. Sun, R. Greenberg, M. Zhang, K. Hawkins, and J. Uhanova Occult hepatitis B infection in a North American adult hemodialysis patient population Hepatology 40 2004 1072 1077
23. O. Chazouilleres, D. Mamish, M. Kim, K. Carey, L. Ferrell, and J.P. Roberts Occult hepatitis B virus as a source of infection in liver transplant recipients Lancet 343 1994 142 146
24. B. Roche, D. Samuel, M. Gigou, C. Feray, V. Virot, and L. Schmets De novo and apparent de novo hepatitis B virus infection after liver transplantation J Hepatol 26 1997 517 526
25. D.D. Douglas, J. Rakela, T.L. Wright, R.A. Krom, and R.H. Wiesner The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient Liver Transpl Surg 3 1997 105 111
26. M.E. Wachs, W.J. Amend, N.L. Ascher, P.N. Bretan, J. Emong, and J.R. Lake The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors Transplantation 59 1995 230 234
27. S.F. Dodson, S. Issa, V. Araya, T. Gayowski, A. Pinna, and B. Eghtesad Infectivity of hepatic allografts with antibodies to hepatitis B virus Transplantation 64 1997 1582 1584
28. R.C. Dickson, J.E. Everhart, J.R. Lake, Y. Wei, E.C. Seaberg, and R.H. Wiesner Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Gastroenterology 13 1997 1668 1674
29. J. Crespo, E. Fabrega, F. Casafont, M. Rivero, G. Heras, and J. de la Pena Severe clinical course of de novo hepatitis B infection after liver transplantation Liver Transpl Surg 5 1999 175 183
30. R. Segovia, A. Sanchez-Fueyo, A. Rimola, L. Grande, M. Bruguera, and J. Costa Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation Liver Transpl 7 2001 106 112
31. M. Prieto, M.D. Gomez, M. Berenguer, J. Cordoba, J.M. Rayon, and J.M. Pastor De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population Liver Transpl 7 2001 51 58
32. I. Villamil, A. Gonzalez-Quintela, A. Aguilera, S. Tome, E. Otero, and F.J. Castroagudin Truly de novo hepatitis B after liver transplantation Am J Gastroenterol 2004 767 768
33. E.K. Yeoh, W.K. Chang, and J.P. Kwan Epidemiology of viral hepatitis B infection in Hong Kong Viral hepatitis B infection in the Western Pacific Region: vaccine and control 1st ed 1984 World Scientific Publications Singapore 0 p. 33-41
34. M. Torbenson, R. Kannangai, J. Astemborski, S.A. Strathdee, D. Vlahov, and D.L. Thomas High prevalence of occult hepatitis B in Baltimore injection drug users Hepatology 39 2004 51 57
35. W. Jilg, E. Sieger, R. Zachoval, and L. Schatz Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus J Hepatol 23 1995 14 20
36. N. Dhedin, C. Douvin, M. Kuentz, M.F. Saint Marc, O. Reman, and C. Rieux Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc Transplantation 66 1998 616 619
37. K. Iwai, M. Tashima, M. Itoh, T. Okazaki, K. Yamamoto, and H. Ohno Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period Bone Marrow Transplant 25 2000 105 108
38. H.S. Conjeevaram, and A.S. Lok Occult hepatitis B virus infection: a hidden menace? Hepatology 34 2001 204 206
39. C. Brechot, V. Thiers, D. Kremsdorf, B. Nalpas, S. Pol, and P. Paterlini-Brechot Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 34 2001 194 203
40. J.A. Marrero, and A.S. Lok Occult hepatitis B virus infection in patients with hepatocellular carcinoma: innocent bystander, cofactor or culprit? Gastroenterology 126 2004 347 350